Tuberkulose, bakterieinfektioner, inklusive sepsis og pneumoni, invasive svampeinfektioner og andre opportunistiske infektioner har været observeret hos patienter, der fik Remicade.
Tuberculosis, bacterial infections, including sepsis and pneumonia, invasive fungal infections, and other opportunistic infections have been observed in patients receiving Remicade.